Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $90.21 | 1.96% | 6.44% | 26.70% | 112.31% | 136.15% | 26.45% | 308.01% | 304.35% | 1,516.67% | $91.00 | $28.66 | 0.87% | 214.76% | 0.99 | 772,000 | -25.55% |
| LQDA | LIQUIDIA CORP | $78.93 | -0.49% | 2.61% | 43.22% | 109.47% | 151.37% | 554.48% | 908.69% | 2,759.78% | N/A | $80.69 | $11.86 | 2.18% | 565.51% | 1.04 | 1,406,000 | 7.33% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $312.78 | 3.68% | 6.69% | 9.32% | -1.90% | -21.84% | -5.15% | 64.89% | 82.45% | 426.39% | $495.55 | $273.11 | 36.88% | 14.53% | 0.89 | 1,093,000 | 4.59% |
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.28 | 3.50% | 11.89% | 38.00% | 37.09% | 12.65% | 75.05% | 224.71% | 94.82% | N/A | $10.08 | $4.62 | 17.86% | 79.22% | 1.23 | 3,753,000 | 37.98% |
| KRYS | KRYSTAL BIOTECH INC | $375.07 | 0.94% | 4.21% | 27.92% | 43.73% | 51.91% | 165.35% | 220.87% | 435.81% | N/A | $382.54 | $130.50 | 1.95% | 187.41% | 1.30 | 235,000 | -20.88% |
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $64.53 | 2.62% | 13.43% | 37.53% | 32.18% | 53.62% | 135.17% | 362.25% | 358.31% | N/A | $64.81 | $26.27 | 0.43% | 145.64% | 0.81 | 626,000 | -4.72% |
| HALO | HALOZYME THERAPEUTICS INC | $79.45 | 3.17% | 9.38% | 19.87% | 23.20% | 13.00% | 47.57% | 115.43% | 71.15% | 828.15% | $82.22 | $53.65 | 3.37% | 48.09% | 0.78 | 1,566,000 | -1.63% |
| VCEL | VERICEL CORP | $46.98 | 4.05% | 9.51% | 36.37% | 37.61% | 31.93% | 13.31% | 25.58% | -9.25% | 2,064.98% | $47.06 | $28.95 | 0.17% | 62.28% | 1.46 | 641,000 | 4.40% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.99 | 2.02% | 2.86% | 10.63% | 6.29% | -0.77% | 3.18% | -31.32% | -30.98% | -26.13% | $66.28 | $49.26 | 11.00% | 19.75% | 0.71 | 1,484,000 | 1.64% |
| RPRX | ROYALTY PHARMA PLC | $57.77 | 3.57% | 5.63% | 6.96% | 18.94% | 48.66% | 59.63% | 88.11% | 36.77% | N/A | $57.80 | $34.08 | 0.05% | 69.51% | 0.46 | 3,245,000 | 34.42% |
| ADMA | ADMA BIOLOGICS INC | $8.95 | 3.95% | 2.64% | 17.76% | -2.61% | -49.94% | -50.66% | 143.87% | 477.42% | 42.97% | $20.46 | $7.21 | 56.25% | 24.13% | 1.20 | 4,367,000 | 43.70% |
| ZVRA | ZEVRA THERAPEUTICS INC | $13.98 | 1.23% | 5.67% | 28.49% | 48.72% | 67.63% | 48.57% | 175.20% | 7.95% | -78.95% | $14.58 | $7.16 | 4.12% | 95.25% | 0.90 | 1,422,000 | 29.51% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.47 | 2.51% | 7.63% | 7.67% | 30.23% | 40.61% | 121.50% | 96.13% | 34.14% | 75.18% | $243.81 | $105.00 | 0.14% | 131.88% | 0.70 | 767,000 | -6.46% |
| ASND | ASCENDIS PHARMA A | $274.50 | 2.51% | 4.94% | 26.73% | 19.74% | 28.70% | 58.58% | 211.44% | 105.10% | 1,968.58% | $274.89 | $160.86 | 0.14% | 70.65% | 0.74 | 552,000 | 6.98% |
| TGTX | TG THERAPEUTICS INC | $53.31 | -0.39% | -0.60% | 45.50% | 58.99% | 82.07% | 46.90% | 134.33% | 32.91% | 788.50% | $57.38 | $25.28 | 7.09% | 110.88% | 1.85 | 3,076,000 | 54.96% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.26 | 3.50% | 9.17% | 20.54% | 34.32% | -0.32% | 16.04% | 6.95% | 25.20% | N/A | $40.87 | $25.52 | 8.83% | 46.00% | 0.82 | 1,013,000 | 37.45% |
| LGND | LIGAND PHARMACEUTICALS INC | $319.55 | 2.42% | 7.99% | 37.29% | 60.10% | 68.09% | 181.15% | 339.73% | 139.81% | 160.28% | $320.99 | $112.83 | 0.45% | 183.21% | 1.12 | 368,000 | -19.47% |
| TECH | BIO-TECHNE CORP | $70.83 | -0.24% | 0.18% | 42.31% | 33.31% | 18.74% | 33.19% | -12.71% | -36.98% | 151.93% | $72.16 | $43.20 | 1.84% | 63.96% | 1.15 | 7,826,000 | -33.77% |
| SPRO | SPERO THERAPEUTICS INC | $2.20 | -0.90% | 8.91% | -22.26% | -9.47% | -6.38% | -24.14% | 49.66% | -86.07% | N/A | $3.22 | $1.80 | 31.68% | 22.22% | 0.79 | 630,000 | 65.35% |
| EXEL | EXELIXIS INC | $55.85 | 3.50% | 4.92% | 15.06% | 27.28% | 28.16% | 26.07% | 191.95% | 205.86% | 593.79% | $56.21 | $33.76 | 0.64% | 65.46% | 0.61 | 2,364,000 | 28.27% |
| VRTX | VERTEX PHARMACEUTICALS INC | $528.04 | 6.03% | 9.97% | 24.22% | 20.36% | 16.79% | 15.54% | 51.92% | 163.31% | 510.38% | $529.14 | $362.50 | 0.21% | 45.67% | 0.57 | 1,856,000 | 54.28% |
| NAGE | NIAGEN BIOSCIENCE INC | $3.43 | 3.00% | 3.63% | -3.11% | -21.69% | -45.12% | -72.73% | 121.29% | -63.55% | -13.82% | $12.65 | $3.18 | 72.89% | 8.03% | 1.50 | 465,000 | -14.99% |
| UTHR | UNITED THERAPEUTICS CORP | $555.91 | 1.60% | 2.30% | 2.94% | -1.58% | 11.92% | 88.30% | 148.45% | 201.58% | 416.02% | $609.35 | $272.12 | 8.77% | 104.29% | 0.41 | 534,000 | 30.88% |
| CPRX | CATALYST PHARMACEUTICALS INC | $31.45 | 0.03% | 0.10% | 0.58% | 27.38% | 35.85% | 46.62% | 146.47% | 456.64% | 4,167.30% | $32.56 | $19.05 | 3.41% | 65.09% | 1.00 | 1,616,000 | 106.39% |
| REGN | REGENERON PHARMACEUTICALS INC | $654.27 | 4.73% | 5.50% | 8.52% | -14.12% | -15.72% | 19.45% | -8.89% | 12.10% | 81.94% | $821.11 | $532.75 | 20.32% | 22.81% | 0.59 | 1,072,000 | 8.61% |
| VCYT | VERACYTE INC | $57.08 | -4.63% | -2.51% | 19.41% | 76.99% | 34.65% | 106.96% | 129.05% | 44.51% | 1,043.89% | $60.91 | $22.61 | 6.29% | 152.45% | 1.90 | 1,150,000 | -3.69% |
| INCY | INCYTE CORP | $116.86 | 2.68% | 8.68% | 26.69% | 21.82% | 15.22% | 71.42% | 88.24% | 39.82% | 46.61% | $118.69 | $66.85 | 1.54% | 74.81% | 0.53 | 2,633,000 | 72.66% |
| SRPT | SAREPTA THERAPEUTICS INC | $19.28 | 5.93% | 20.35% | 18.65% | -17.00% | -9.53% | 5.96% | -83.01% | -74.38% | -4.88% | $25.32 | $10.42 | 23.85% | 85.12% | 1.07 | 4,358,000 | 29.51% |
| MDXG | MIMEDX GROUP INC | $3.95 | 1.28% | 3.67% | 10.64% | 0.77% | -39.04% | -36.60% | -40.15% | -68.15% | -50.99% | $7.99 | $3.03 | 50.56% | 30.58% | 1.27 | 662,000 | -6.63% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.